GlaxoSmithKline
GSK
#216
Rank
S$124.21 B
Marketcap
S$61.32
Share price
-2.48%
Change (1 day)
31.42%
Change (1 year)

GlaxoSmithKline (GSK) - Net assets

Net assets on the balance sheet as of September 2025 : S$27.46 Billion

According to GlaxoSmithKline's latest financial reports the company has S$27.46 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

GlaxoSmithKline - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$22.32 B3.68%
2023-12-31$S$21.52 B31.48%
2022-12-31$S$16.37 B-57.96%
2021-12-31$S$38.94 B3.8%
2020-12-31$S$37.52 B15.62%
2019-12-31$S$32.45 B409.64%
2018-12-31$S$6.36 B0.97%
2017-12-31$S$6.30 B-28.84%
2016-12-31$S$8.86 B-52.38%
2015-12-31$S$18.61 B83.27%
2014-12-31$S$10.15 B-37.8%
2013-12-31$S$16.32 B22.61%
2012-12-31$S$13.31 B-25.05%
2011-12-31$S$17.76 B-8.31%
2010-12-31$S$19.37 B-20.59%
2009-12-31$S$24.40 B39.97%
2008-12-31$S$17.43 B-38.52%
2007-12-31$S$28.35 B-2.11%
2006-12-31$S$28.96 B33.31%
2005-12-31$S$21.73 B12.86%
2004-12-31$S$19.25 B-25.06%
2003-12-31$S$25.69 B25.01%
2002-12-31$S$20.55 B-8.8%
2001-12-31$S$22.53 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
S$59.63 B 117.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$120.76 B 339.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$67.33 B 145.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$58.05 B 111.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$111.94 B 307.52%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
S$9.40 B-65.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
S$0.69 B-97.48%๐Ÿ‡บ๐Ÿ‡ธ USA